Skip to content

Neurobiological and behavioural aspects of social aggression in healthy men and women

Neurobiological and behavioural aspects of social aggression in healthy men and women - Neurobiology of social aggression

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33163
Enrollment
120
Registered
2009-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social aggression

Interventions

None listed

Sponsors

Universiteit Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Good health Right-handedness Non-smoking Aged between 18-40 years Normal or corrected-to-normal vision Signed informed consent

Exclusion criteria

Exclusion criteria: Metal in cranium 15 alcoholic beverages per week Use of psychotropic drugs, including cannabis, XTC, amphetamines and cocaine Epilepsy or family history of epilepsy (1st degree relatives) History of closed-head injury History of neurological or psychiatric disorders and/or treatment Current neurological or psychiatric treatment History of endocrinological disorders and/or treatment Current endocrinological treatment Medication: Benzodiazepines, antidepressants & neuroleptica Cardiac pacemaker Implanted medication pump Intra-cardiac lines Habitual smoking Pregnancy

Design outcomes

Primary

MeasureTime frame
Main study parameters in the proposed study are the inter-individual differences in relations between cortico-cortical functional connectivity, behavioural measures and personality characteristics. In two of the four proposed substudies the collected endocrine measures will also be related to cortico-cortical functional connectivity, behavioural measures and personality characteristics.

Secondary

MeasureTime frame
Subject's demographics, motorthreshold values (part of the transcranial magnetic stimulation procedure).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)